詳細検索結果
以下の条件での結果を表示する: 検索条件を変更
クエリ検索: %22%E7%81%AB%E5%A4%AB%22
4,941,643件中 1-20の結果を表示しています
  • 増田 精造
    日本化学会誌(化学と工業化学)
    1982年 1982 巻 3 号 500-504
    発行日: 1982/03/10
    公開日: 2011/05/30
    ジャーナル フリー
    塩化亜鉛存在下で,アリルベンゼン(
    AB
    )とアクリル酸メチル(MA),メタクリロニトリル(MAN)アクリロニトリル(AN),メタクリル酸メチル(MMA)およびフマロニトリル(FN)とのラジカル共重合を行なった。
    AB
    -MA,
    AB
    -MANおよび
    AB
    -AN系では,塩化亜鉛の存在の有卿こかかわらず共重合が起こるが,
    AB
    -MMAおよび
    AB
    --FN系では,塩化亜鉛が存在しなければ共重合は起こらない。
    AB
    -FN系では,仕込み比に関係なく交互共重合体が得られる。
    AB
    -ANおよび
    AB
    -MMA系では,塩化亜塩の添加量が増加するにつれて,見かけのモノマー反広も性比は減少する。このことは,塩化亜鉛が生長反応に関与していることを示唆している。そこで,これらの系をAN(またはMMA)の遊離モノマー(M,),AN(またはMMA)の錯体モノマー(M2)・および
    AB
    (Ms)のランダム三元共重合体であるとして,共重合組成式を導き,得られる値から個々のモノマー反応性比を求めた。
    AB
    -AN系では,k11/k12=0.13,k11/k18=
    5
    .1,k
    22
    /k21=1.05およびk
    22
    k/k23=0.85であった。また,
    AB
    -MMA系にについては,k11/k12=0.024,k
    22
    /k21=0.91およびk
    22
    /k23=8.57が得られた。モノマー反癒性比におよぼす陽イオンおよび陰イオンの効果についても検討した。
  • 高橋 崎三, 鈴木 信行, 大日向 充, 大堀 勉, 沼里 進
    CHEMOTHERAPY
    1978年 26 巻 Supplement4 号 118-129
    発行日: 1978/09/25
    公開日: 2011/08/04
    ジャーナル フリー
    AB
    -206 (
    5
    , 8-dihydro-
    5
    -methoxy-8-oxo-2 H-1, 3-dioxolo-[
    4
    ,
    5
    -g] quinoline-
    7
    -carboxylic acid) was administered orally to a total of
    22
    cases of various urinary tract infections in dosages of 500 to 1, 500 mg/day for a period of 3 to 10 days. The following results were obtained.
    1) Among 6 cases of acute simple cystitis, the therapeutic results were rated as excellent in 3 cases, and as good in 3 cases, with an efficacy rate of 100%. Regarding 9 cases of chronic urinary tract infections, the results were rated as excellent in 1 case, as good 2 cases and poor in 6 cases. Thus, the efficacy rate in these cases became 33. 3%. Six cases which failed to respond to
    AB
    -206 were all diagnosed as having chronic urinary tract infections. In all, the results of treatment were rated as excellent in
    4
    cases, as good in
    5
    cases and as poor in 6 cases. The efficacy rate was 60.0%.
    2) An inspection of the results as classified by the causative organisms revealed that
    AB
    -206 ishighly active against
    E
    . coli
    and that it is also active against Serratia marcescens, Acinetobacter anitratum and Proteus mirabilis.
    3) MIC of
    AB
    -206 for 26 strains of organisms isolated from 16 out of
    22
    cases was determined and compared to that of NA and ABPC. It was shown that
    AB
    -206 was much more active than NA and ABPC against Serratia marcescens and that in general it was equally or slightly more active against other species of organisms. However, against Enterococcus ABPC was superior to
    AB
    -206 and NA.
    4
    ) The adverse reactions observed were nausea, dizziness and nausea associated with dizziness in one case each, all of which were mild and transient in nature. With respect to peripheral blood and liver and renal functions, no abnormal findings which could be related to treatment with
    AB
    -206 were observed.
  • 中富 昌夫, 那須 勝, 岩崎 博円, 大田 迪祐, 斎藤 厚, 森 信興, 広田 正毅, 堀内 信宏, 林 敏明, 朝長 昭光, 原 耕平, 餅田 親子, 猿渡 勝彦, 伊折 文秋, 林 愛
    CHEMOTHERAPY
    1978年 26 巻 Supplement4 号 310-319
    発行日: 1978/09/25
    公開日: 2011/08/04
    ジャーナル フリー
    Fundamental and clinical studies on
    AB
    -206, a new antimicrobial agent, were carried out and the following results were obtained:
    1. Antimicrobial activity:
    Minimal inhibitory concentrations (MICs) of
    AB
    -206 against
    22
    standard strains which had been subcultured in our department and 664 strains (Staphylococcus aureus 54, Salmonella 36, Citrobacter freundii 38, C. diversus 24, C. amalonatica 10,
    E
    . coli
    53, Shigella 45, Klebsiella aerogenes 53, Enterobacter aerogenes 54, Ent. cloacae 54, Serratia marcescens 54, Proteus vulgaris 13, Pr. mirabilis 41, Pr. rettgeri
    22
    , Pr. inconstans 16, Morganella morganii 43, Pseudomonas aeruginosa 54) isolated from the various clinical materials were determined in comparison with those of nalidixic acid (NA). MICs of
    AB
    -206 were 2 to
    4
    times lower than those of NA in almost all bacteria.
    2. Absorption and excretion in man:
    Three healthy male adults were given 500 mg of
    AB
    -206 orally at fasting time and the peak serum levels were
    5
    .3 to 6.25μg/ml 1 to 2 hours after administration. Two healthy male adults were also given 500 mg of
    AB
    -206 orally after meal and the peak serum levels were 3.8 to 6.25μg/ml 2 to
    4
    hours afterwards.
    A 54 years old female patient with chronic bronchitis was administered 500 mg of
    AB
    -206 after meal and its peak level of the drug was
    5.8μg
    /ml
    4
    hours after medication. Urinary recovery rates within 6 hours were
    5
    .
    4
    to
    7
    .8%.
    3. Clinical effect:
    Five patients with pulmonary infections (Bronchopneumonia 2, Bronchiectasis 1, Chronic bronchitis 1, Acute bronchitis 1) were treated by 1, 500 mg of
    AB
    -206 per day. Clinical and bacteriological effectiveness was poor in all five cases.
    4
    . Adverse reaction:
    Subjective and objective symptoms and hematological, biochemical data and renal function were checked up after administration of
    AB
    -206. No side effect was observed.
  • 松田 静治, 柏倉 高, 丹野 幹彦
    CHEMOTHERAPY
    1978年 26 巻 Supplement4 号 365-371
    発行日: 1978/09/25
    公開日: 2011/08/04
    ジャーナル フリー
    A newly synthesized antibiotic
    AB
    -206 was studied bacteriologically and clinically in the field of obstetrics and gynecology with predominance on urinary tract infections. The following results were obtained:
    1) Tests of antibacterial activities of
    AB
    -206 against various bacteria revealed that MICs for
    E
    . coli
    , Klebsiella, Proteus mirabilis and Proteus vulgaris were lower than those of NA and PPA. In addition,
    AB
    -206 was proven to be active against Pseudomonas aeruginosa.
    2) A total of 33 cases consisting of those of acute simple cystitis, chronic cystitis and genital organ infections were treated with
    AB
    -206, and 72.
    7
    % of the cases responded to
    AB
    -206.
    3) The effectiveness of
    AB
    -206 in the treatment of urinary tract infections was determined, and it was found that the efficacy rate obtained in chronic cystitis was 44.
    4
    %, while that in acute simple cystitis caused chiefly by
    E
    . coli
    was
    81
    .0%.
    4
    ) No notable side effects were observed.
  • ~特に6-MPと併用するステロイドホルモンの投与量の問題~
    和田 義夫
    医療
    1967年 21 巻 3 号 369-376
    発行日: 1967/03/20
    公開日: 2011/10/19
    ジャーナル フリー
    The material consists of 140 patients with AML who were registered from July 1, 1959 to November 30, 1963, Only those who presented themselves without receiving any treatment were included. They were divided into two age groups, i.
    e
    ., children group (below 15 years) and adults group (15 years or over). One of therapeutic schedules was chosen by opening a sealed envelope containing the schedule to be applied, i.
    e
    ., the small dosage of Prednisolone 0.
    5
    mg/kg/day (Aa) or the large dosage of Prednisolone 2mg/kg, 'day (
    Ab
    ), in association with an ordinary dosage of 6-MP, i.
    e
    ., 2-3mg/kg/day. The schedule was continued
    4
    -8 weeks till a remission was acquired or toxic manifestations prevented further administration. Results: In children, remissions were acquired in 52.49 (11/21) in the Aa and in 55.0% (11/20) in the
    Ab
    . The total remission rate in children was 53.
    7
    % (
    22
    /41). In adults, remissions were gained in 28.6% (14/49) of the Aa and in 20.0% (10/50) of the
    Ab
    . The total remission rate in adults was 24.3% (24/99), Thus lower rates of remission were noted in large dosage of Prednisolone in adults, but the difference are not statistically significant. The numbers of survived at 8 weeks after start of treatments were compared. In children, the survival rates were 61.9% in the Aa and in 65.0% in the
    Ab
    in both dosage groups, while in adults it was 42.8% in the Aa and 34.9% in the
    Ab
    . Among steroidhormones, Prednisolone “Takeda” was used in the first half period and Dexamethasone (Orgadrone with Prednisolone equivalent dosage) was used in the second half. No significant differences in the remission rate and survival rate were found between these two drugs.
    Conclusion: From our experience of 140 cases of AML, it was concluded that the large lose of Prednisolone or of Dexamethasone should not be administered to all patients without preselection.
  • 真弓 美帆, 西森 洋介, 纐纈 明伯, 関 寿
    日本結晶成長学会誌
    1999年 26 巻 2 号 22-
    発行日: 1999/07/01
    公開日: 2017/05/31
    ジャーナル フリー
    In situ gravimetric monitoring of atomic layer epitaxy (ALE) of a cubic-GaN on GaAs (001) is investigated by a halogen transport system using GaCl and NH3 sources. The cubic-GaN growth of one monolayer / cycle is obtained at the temperature range from 350 to 400℃. The growth rate decreases with increasing temperature, and then the growth rate in one ALE cycle keeps a constant at about 0.45 from 410 to 450℃. Also, it is shown that a pure cubic-GaN can be grown by a halogen transport ALE.
  • 清水 哲夫, 福田 常男, 加藤 兼房
    日本輸血学会雑誌
    1984年 30 巻 1 号 9-13
    発行日: 1984年
    公開日: 2010/03/12
    ジャーナル フリー
    A sandwich enzyme immunoassay method for measuring a platelet-specific protein, platelet factor
    4
    (PF
    4
    ) was developed by mean of purified antibodies to PF
    4
    . The assay system consisted of polystyrene balls with immobilized antibody F(
    ab
    ′)2 fragments and the same antibody Fab′ fragments labeled with β-D-galactosidase from
    E
    . coli. The measurable range was from 30pg to 3ng of PF
    4
    per each tube. The results obtained with the enzyme immunoassay correlated well with those of a radioimmunoassay (γ=0.952, y=0.954x+2.43; n=36). The plasma PF
    4
    levels in healthy subjects were 6.
    4
    ±1.
    4
    ng/ml (±1 SD).
    The levels of PF
    4
    in platelet rich plasma obtained by platelet apheresis were 14.
    7
    ±
    1.5μg
    /109 cells. Platelets contained large amounts of PF
    4
    , while, the levels of PF
    4
    in red blood cells and lymphocytes were very low, confirming the previous findings that PF
    4
    is localized mainly in blood platelets. The levels of PF
    4
    in plasma of platelet concentrates processed 24hr before and stored at
    22
    °C were high (3.
    22
    ±1.43μg/ml).
  • 緒方 富雄, 松橋 直, 臼井 美津子
    日本輸血学会雑誌
    1959年 6 巻 4 号 181-184
    発行日: 1959年
    公開日: 2010/03/12
    ジャーナル フリー
    Out of 3100 separate blood specimens sent to our department about 800 specimens were examined for detection of irregular antibodies. In about 60 cases irregular antibodies were found and specificity of
    22
    sera were identified, which are summarized as follows:
    1) Sera of 10Rh negative female contained anti-D, most of which were produced by isoimmunization during pregnancy. A serum of Rh negative male contained anti-D produced by incompatible blood transfusions.
    2) Sera of
    4
    E
    -negative female contained anti-
    E
    produced presumably by pregnancy. A serum of
    E
    -negative contained anti-
    E
    produced by incompatible blood transfusions.
    3) An example anti-M antibody was found at the time of crossmatching test.
    4
    ) In 2 cases of acquired hemolytic anemia both anti-c and anti-
    E
    were found.
    5
    ) A case of aplastic anemia demonstrated anti-S and anti-Jkb.
    6) Two professional
    AB
    donors sera contained irregular antibodies anti-A1 and anti-Lea respectively.
  • ステロイドCD環および側鎖の立体選択的合成
    高橋 孝志
    有機合成化学協会誌
    1986年 44 巻 1 号 21-37
    発行日: 1986/01/01
    公開日: 2009/11/13
    ジャーナル フリー
    Four synthetic routes to steroid CD-ring synthons possessing various side chains, and two methods for stereospecific introduction of steroid side chains at C (20) are presented. In the first approach, (-) - (R) - [3 (R) -hydroxy-
    5
    -methyl-1 (Z) -hexenyl] - (
    7aR
    ) -methyl-
    4
    -hydroinden-
    5
    -one (
    4
    ) and (+) - (1R) -acetyl- (
    7aR
    ) -methyl-
    4
    -hydroinden-
    5
    -one (32) were synthesized by highly enantioselective double Michael addition of a chiral alkenyl copper-phosphine complex to 2-methyl-2-cyclopentenone in which C (23R) -allylic alcohol moiety served to control the cis stereochemistry at C (17) and C (13) as a key reaction. In the second approach, (±) -De-
    AB
    -cholestan-9-one (50) was synthesized by highly stereoselective double Claisen rearrangements of allylic alcohol 54, the first one to introduce the acyl chain at C (14) and the second to introduce the chain at C (13) with the right trans stereochemistry between 18-methyl and C (14) hydrogen, as well as the geometry of the [17 (20)
    E
    ] -olefin. The C-ring was constructed by the cyclization of acyl carbanion and the side chain was introduced by the alkylation of the secondary tosylate 51 with acyl carbanion 70. (±) -De-
    AB
    -cholest-8 (14),
    22
    -diene-9-one (74) and its optically active form were synthesized, in the third and fourth approaches, by double Claisen rearrangements of (±) -triol 78 and the palladium-catalyzed cyclization of (+) -1, 3-diene monoepoxide 122, respectively. In both approaches, the cis relative stereochemistry between 18-methyl and side chain at C (17) was introduced by the product development controlled methylation of 2-butenyl-3-alkylvalerolactone. In the syntheses of side chains, the 20 (R) -and 20 (S) -configurations were introduced by the alkylation of 20-tosyloxy steroids with the protected cyanohydrin 131 and by the palladium-catalyzed 1,
    4
    -addition of nucleophiles to 15, 16-epoxy-
    E
    -17 (20) -alkylidene steroids.
  • 青河 寛次, 皆川 正雄, 柄川 二郎, 山路 邦彦, 杉山 陽子
    CHEMOTHERAPY
    1978年 26 巻 Supplement4 号 377-383
    発行日: 1978/09/25
    公開日: 2011/08/04
    ジャーナル フリー
    We studied the antibacterial activity of synthetic antibacterial agent
    AB
    -206, its serum levels and clinical results, and obtained the following findings.
    1. The sensitivity distribution of
    AB
    -206 for clinical isolates proved to be superior to that of nalidixic acid. The compound's MIC was found to be between 6.25 and
    12.5μg
    /ml for 91.
    4
    % of Sta. aureus, while it was less than 0.78 μg/ml for 94% of
    E
    . coli
    . Ninety percent of Klebsiella isolates were inhibited by a MIC of less than 6.25 μg/ml, but Pseudomonas aeruginosa required a MIC of more than 12.
    5
    , μg/ml.
    2. Healthy women given
    AB
    -206 in a dose of 500 mg at the time of fasting showed maximum serum levels of over
    5μg
    /ml at 1-2 hours, and the drug could be traced in serum until several hours later.
    Higher serum levels could be obtained in patients with hepatic dysfunction indicating 3-grade icterus index.
    3)
    AB
    -206 was orally given to a total of
    22
    cases consisting of
    5
    cases of asymptomatic bacteriuria, 10 cases of acute simple cystitis,
    4
    cases of chronic urinary tract infection and 3 cases of complicated urinary tract infection in a dose schedule of 250 or 500 mg 3 to
    4
    times a day for
    5
    -14 days. It was found effective in 17 cases. No remarkable side-effect was induced by administration of
    AB
    -206 nor abnormal changes were seen in laboratory findings after the therapy.
  • 小島 愛司
    CHEMOTHERAPY
    1967年 15 巻 5 号 549-559
    発行日: 1967年
    公開日: 2010/09/24
    ジャーナル フリー
    1) Experimental cholecystitis in dogs was produced by injecting
    E
    . coil
    (NIHJ and C-43 strain) and
    5
    % sodium desoxycholate into the gallbladder. In postmortem examination, bile usually contained about 106/m1 of
    E
    . coil
    possessing same susceptibility patterns to the original microorganisms. Pathological studies of these. gallbladders revealed signs of inflammation.
    2) The produced cholecystitis was treated with th ree antibiotics?chloramphenicol (CP), kanamycin (KM), aminobenzyl-penicillin (
    AB
    -PC)--for 1 week. More or less effects were obtained from the treatment with these drugs with the exception of KM. Especially,
    AB
    -PC group was most successfully treated. The cholecystitis produced with
    E
    . coil
    susceptible to CP responded more effectively than those with the microorganism moderately resistant to this antibiotic. In addition to these results, the observation of the blood and biliary concentration of these three antibiotics (100 mg/kg 1. m. ) for 24 hours, revealed the fact that the latter played more important role in the treatment of experimen tal cholecystitis.
    3) Injecting
    E
    . coli
    adapted to 2% desoxycholate, in vitro, more severe inflammation was produced than the cases with unadapted microorganism.
    4
    ) Determination of hemaggl utinin titer was carried out in order to study the process of inflammation. In normal dogs without infection, average H. A. titer of
    22
    has obtained. In non-treated group without chemotherapy, significant high titer up to 28 was observed on
    7
    th day. In the treated group, fluctuation of the titer was observed in proportion to the effects of treatment. The grade and process of inflammation may be evaluated by the method of hemagglutination reaction.
  • José A. Martínez-Flores, Manuel Serrano, Dolores Pérez, Gómez de la Cámara A, David Lora, Luis Morillas, Rosa Ayala, Estela Paz-Artal, José M. Morales, Antonio Serrano
    Journal of Atherosclerosis and Thrombosis
    2016年 23 巻 10 号 1242-1253
    発行日: 2016/10/01
    公開日: 2016/10/01
    [早期公開] 公開日: 2016/04/11
    ジャーナル オープンアクセス

    Aim: Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis and/or gestational morbidity in patients with antiphospholipid autoantibodies (aPL). Over recent years, IgA anti-beta2-glycoprotein I (B2GPI) antibodies (IgA

    aB
    2GPI) have reached similar clinical relevance as IgG or IgM isotypes. We recently described the presence of immune complexes of IgA bounded to B2GPI (B2A-CIC) in the blood of patients with antecedents of APS symptomalology. However, B2A-CIC's clinical associations with thrombotic events (TEV) have not been described yet.

    Methods: A total of 145 individuals who were isolate positive for IgA

    aB
    2GPI were studied: 50 controls without any APS antecedent,
    22
    patients with recent TEV (Group-1), and 73 patients with antecedents of old TEV (Group-2).

    Results: Mean B2A-CIC levels and prevalence in Group-1 were 29.6±

    4
    .1 AU and
    81
    .8%, respectively, and were significantly higher than those of Group-2 and controls (p<0.001). In a multivariable analysis, positivity of B2A-CIC was an independent variable for acute thrombosis with a
    22
    .
    7
    odd ratio (confidence interval
    5
    .1–101.6, 95%, p<0.001). Levels of B2A-CIC dropped significantly two months after the TEV. B2A-CIC positive patients had lower platelet levels than B2A-CIC-negative patients (p<0.001) and more prevalence of thrombocytopenia (p<0.019). Group-1 had no significant differences in C3 and C
    4
    levels compared with other groups.

    Conclusion: B2A-CIC is strongly associated with acute TEV. Patients who did not develop thrombosis and were B2A-CIC positive had lower platelet levels, which suggest a hypercoagulable state. This mechanism is unrelated to complement-fixing aPL. B2A-CIC could potentially select IgA

    aB
    2GPI-positive patients at risk of developing a thrombotic event.

  • Keishi Hata, Fuyuki Sugawara, Naganori Ohisa, Saori Takahashi, Kazuyuki Hori
    Biological and Pharmaceutical Bulletin
    2002年 25 巻 8 号 1040-1044
    発行日: 2002年
    公開日: 2002/08/01
    ジャーナル フリー
    We screened the differentiation-inducing activities of 39 mushroom extracts from Akita prefecture, Japan, on the mouse osteoblastic cell line, MC3T3-
    E
    1. Sixteen phosphate buffered saline (PBS), 8 boiled PBS, 14 ethanol and 12 methanol extracts induced alkaline phosphatase (ALP) activities, an indicator of MC3T3-
    E
    1 cell differentiation. The enzyme activities were markedly induced by extracts of Tricholoma auratum, and we isolated the active compound from methanol extracts of this mushroom. Physical data for the isolated active compound were identical to those for (
    22E
    ,24R)-ergosta-
    7
    ,
    22
    -diene-3β,
    ,6β-triol (1). 1 induced ALP activities of MC3T3-
    E
    1 cells and promoted cell proliferation. To investigate the relationships between the chemical structure and differentiation-inducing activity of the compound, ALP-inducing activities of MC3T3-
    E
    1 cells by 1, ergosterol (2), ergocalciferol (3), cholesta-3β,
    ,6β-triol (
    4
    ),
    7
    -dehydrocholesterol (
    5
    ) and cholecalciferol (6) were tested. The enzyme activities of MC3T3-
    E
    1 cells were increased 3.0-fold by 10 μM 1 and 2.
    4
    -fold by 10 μM
    4
    . However, 2, 3,
    5
    and 6 did not induce MC3T3-
    E
    1 cell ALP activity at 0.1—10 μM. These results suggested that the OH groups at C-
    5
    and/or C-6 of 1 and
    4
    played an important role in their differentiation-inducing activities on MC3T3-
    E
    1 cells. Furthermore, 1 suppressed induction of MC3T3-
    E
    1 cell apoptosis by serum starvation.
  • 島 正幸, 西村 拓也, 吉岡 章, 福井 弘, 西田 幸世, 辻内 智美, 藤村 吉博
    日本輸血学会雑誌
    1992年 38 巻 4 号 542-547
    発行日: 1992/09/15
    公開日: 2010/03/12
    ジャーナル フリー
    On blood group ABO, A antigen is converted from O antigen (H-substance) with A-transferase, whereas B antigen from the same substrate with B-transferease. Yamamoto et al (Nature, 345: 229-233, 1990) recently elucidated cDNA sequence of ABO genes, and showed the differences among A, B, and O allelic cDNAs. Therefore, the determination of ABO-genotype can be analysed by means of PCR of genomic DNAs and digestion of the PCR-products with restriction enzymes at the different points of nucleotides. We collected blood samples from a total of 52 Japanese healthy volunteers (30 female and
    22
    male), which include 16 A-type, 14 B-type, 10 O-type, and 12
    AB
    -type, and defined the ABO genotype utilizing PCR and restriction enzymes. The results are followings; 3 AA (18.8%) and 13 AO (
    81
    .2%) in phenotype A,
    5
    BB (35.
    7
    %) and 9 BO (64.3%) in phenotype B. No conflict results were observed in individuals with phenotypes
    AB
    and O.
  • Deni Pranowo, Nuryono, Ali Agus, Jumina, Romsyah Maryam, FMCS Setyabudi
    マイコトキシン
    2017年 67 巻 2 号 77-83
    発行日: 2017/07/31
    公開日: 2017/09/01
    ジャーナル フリー

     AFB1抗体の封入のために,コメ籾殻灰からのシリカの抽出ならびにイムノアフィニティカラムIAC)のマトリクスとしての適用を行った.コメ籾殻灰抽出は

    4
    M NaOHで行い,シリカゲル合成のためのNa2SiO3が得られた.得られたシリカはゾル-ゲル法により,AFB1抗体の封入のために使われた.

     1 mlの1M Na2SiO3:

    H2O:H3PO4
    (0.43:0.11:0.46)は,pH
    7
    で,1.36 mgの
    Ab
    -AFB1を封入するのに適したシリカゲルを産生した.

     48時間のエイジング後,AFB1抗体修飾されたシリカゲル(SG-

    Ab
    - AFB1)は粉砕され,アフラトキシン精製用のIACのマトリクスとして充填された.修飾されたシリカゲルは,FTIRとSEMにより観察された.SG-
    Ab
    - AFB1のIACとしての性能はAF回収率,負荷能,再利用可能性で評価された.AFB1の回収率は94.11 ±
    4
    .62%であった.AFB1に加えて,本カラムはAFB2,AFG1とAFG2を,それぞれ98.
    22
    ± 3.74%,92.
    22
    ±
    7
    .62%,83.00 ± 6.31%という回収率で回収できた.

     0.

    5
    gのSG-
    Ab
    - AFB1を充填した本カラムは,カラム1本当たり50 ngのAFを結合する能力を持ち,少なくとも
    5
    回は,回収率80%以上で再利用可能であった.

  • 徐 慶一郎, 三辺 武右衛門, 村上 温子, 西崎 恵子
    CHEMOTHERAPY
    1971年 19 巻 8 号 1072-1078
    発行日: 1971/11/25
    公開日: 2011/03/08
    ジャーナル フリー
    1. The MIC of sulfobenzylpenicillin (SB-PC) against 34 strains of Staph. aureus and 32 strains of
    E
    . coli
    was compared with that of carbenicillin (CB-PC). No remarkable difference existed between the 2 drugs about the MIC against Staph. aureus and
    E
    . coli
    strains.
    2. The anti-staphylococcal activities of SB-PC and CB-PC were compared by the effect on the growth curve, automatically traced by biophotometer. The results have shown that SB-PC is a little stronger in anti-staphylococcal activity than CB-PC at the dose of 1 mcg/ml.
    3. The anti-staphylococcal activities of sera after administration of SB-PC, 500 mg i. m., were tested in the same way. The sera taken 30 min., 1 hr., and 3 hrs. after administration were active, but that taken 6 hrs. after administration was not active.
    4
    . The lytic action of SB-PC, CB-PC and aminobenzylpenicillin (
    AB
    -PC) against Staph. aureus 209 P and
    E
    . coli NIHJ was examined by adding the drug at the logarythmic phase of growth stage. The activities of the 3 drugs were equal against Staph. aureus. Against
    E
    . coli
    , SB-PC and CB-PC had equal activity but less than
    AB
    -PC activity.
    5
    . Fourty-five cases of otorhinolaryngeal infections were treated with SB-PC and the results were obtained as follows : remarkably effective, 29 cases (64.
    5
    %); improved, 10 cases (
    22
    .2%); ineffective, 6 cases (13.3%); efficacy rate, 86.
    7
    %.
    6. As side effects, 1 case of fever and 1 case of unwell were noted in addition to the pain at the site of injection.
  • 濱田 喜樹, 杉浦 道治, 廣田 穣
    YAKUGAKU ZASSHI
    1978年 98 巻 10 号 1361-1369
    発行日: 1978/10/25
    公開日: 2008/05/30
    ジャーナル フリー
    1, 3-Dialkoxy-
    4
    -bromo-2-cyano-1, 2, 3,
    4
    -tetrahydroisoquinolines (2
    ab
    , 8
    ab
    to 11
    ab
    ) are obtained quantitatively by the addition of cyanogen bromide to isoquinoline (1) dissolved in the corresponding alcohol, followed by application of bromine and saturated sodium carbonate solution. These products are a mixture of stereoisomers with the hydrogen atoms in 3- and
    4
    -positions in cis (main) and trans configuration. Dehydrobromination of the cis-type compounds with potassium cyanide easily gives 3-alkoxyisoquinolines (
    7
    , 12-15). Hydrolysis of with conc. hydrochloric acid affords
    4
    -bromoisoquinoline (
    5
    a) from cis-type compounds and
    4
    -chloroisoquinoline (
    5
    b) from trans-type compounds. It had been difficult to obtain compounds
    7
    and 12 to 15.
    4
    -Bromo-
    5
    -nitroisoquinoline (21) was obtained from
    5
    -nitroisoquinoline (18) by the application of the above reaction but 3-methoxy-
    5
    -nitroisoquinoline (
    22
    ) could not be obtained. Application of this reaction to 1, 6-naphthyridine easily gave 8-bromo-1, 6-naphthyridine (27) and
    7
    -methoxy-1, 6-naphthyridine (28), compounds in which a substituent had been introduced into the
    7
    - and 8-positions that had never been attempted so far.
  • Suguru TAKATSUTO, Kiyomi KOBAYASHI, Tsuyoshi WATANABE, Hiroki KURIYAMA, Tokuo FURUSE
    Agricultural and Biological Chemistry
    1988年 52 巻 12 号 3217-3218
    発行日: 1988年
    公開日: 2006/04/05
    ジャーナル フリー
  • Zsuzsa JANOSFALVI, Fumihiko MATSUI, Nobuaki TAKAHASHI, Muneoki AKASAKA, Hidetoshi NAMBA, Hiroshi DAIMON
    日本物理学会講演概要集
    2007年 62.2.4 巻 22pPSA-7
    発行日: 2007/08/21
    公開日: 2018/03/03
    会議録・要旨集 フリー
  • II動物の健康時における血液ガス値について
    小笠原 成郎
    日本獣医師会雑誌
    1960年 13 巻 10 号 434-438
    発行日: 1960/10/20
    公開日: 2011/06/17
    ジャーナル フリー
    The following average values were determined. on all or some of 27 Saanen goats, 19 Holstein-Friesian and
    4
    Jersey cows,
    7
    Japanese native black oxen, and 13 dogs, all of which were healthy.
    1. The oxygen content on a volume per cent basis of the arterial blood (
    AB
    ) was 14.059 in goats (G) and 14.71 in cattle (C). That of the venous blood (VB) was 9.72 in G, 10.71 in C, and 10.74 in dogs (D).
    2. The oxygen capacity on a volume per cent basis was 15.25 in G, 15.98 in C, and 16.66 in D.
    3. Oxygen per cent saturation in
    AB
    was 89.37 in G and 91.
    5
    in C. That in VB was 63.83 in G, 67.20 in C, and 64.71 in D.
    4
    . The CO2 pressure in mmHg of
    AB
    was 41. 76 in G and 37.9 in C. That of VB was 47.08 in G, 42.6 in C, and 43.
    5
    in D.
    5
    . The total CO2 on a volume per cent (and MM/L) basis of
    AB
    was 56.43 (25.63) in G and 52.08 (23.55) in C. That of VB was 61.08 (27.63) in G, 56.53 (25.53) in C, and 58.44 (26.40) in D.
    6. The free CO2 (as H2CO3) on an MM/L basis of
    AB
    was 1.31 in G and 1.19 in C. That of VB was 1.47 in G, 1.33 in C, and 1.36 in D.
    7
    . The combinative CO2 (as HCO3-) on an ME Q/L basis of
    AB
    was 25.12 in G and
    22
    .61 in C. That of VB was 26.10 in G, 24.19 in C, and 25. 12 in D.
    8. The plasma buffer base (BB+) on an mEQ/L basis of
    AB
    was 42.57 in G and 40.2 in C. That of VB was 43.46 in G, 41.3 in C, and 41.98 in D.
    9. The pH of
    AB
    was
    7
    .39 in G and
    7
    .40 in C. That of VB was
    7
    .36 in G and C and
    7
    .37 in D.
feedback
Top